from Ins2
Akita mice, whereas other sEH substrates and products were unaffected (Extended Data Fig. 2a ). Of the epoxide hydrolases, only Ephx2 (which encodes sEH) expression was significantly increased in retinas from Ins2 Akita mice (Extended Data Fig. 2b ), and sEH expression and activity also increased in retinas from wild-type animals fed a high-fat, high-carbohydrate diet for 20 weeks that displayed hyperglycaemia but no clear signs of retinopathy (Extended Data Fig. 2c-i) . Importantly, the expression of sEH increased with disease severity in retinas from patients with non-proliferative diabetic retinopathy versus those without diabetes ( Fig. 1d -f, Extended Data Table 1) . It was only possible to obtain samples of vitreous humour from patients with proliferative diabetic retinopathy, and at this later stage of the disease, levels of the sEH substrate epoxydocosapentaenoic acid (19,20-EDP) and the sEH product 19,20-DHDP were significantly higher in samples from patients with diabetic retinopathy than with idiopathic macular holes but without diabetes (Fig. 1g , Extended Data Table 2 ).
To assess the contribution of sEH to disease progression, studies were performed using the sEH inhibitor trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]-benzoic acid (t-AUCB) 8 , which was able to cross the blood-retinal barrier and could be detected in the retina (4.56 ± 0.86 ng g −1 retina; mean ± s.e.m.) after one week of treatment. t-AUCB (given from 6 weeks to 12 months) did not affect body weight, fasting levels of blood glucose, blood pressure or heart rate (Extended Data Fig. 1a-d ), but significantly attenuated the production of 19,20-DHDP (Fig. 1h) . All of the characteristic changes associated with non-proliferative diabetic retinopathy (such as decreased pericyte numbers, increased extravascular pericytes, acellular capillaries and permeability) were evident in 12-month-old Ins2
Akita animals, and were clearly attenuated by treatment with sEH inhibitor (Fig. 2a-g ).
Pericytes are the first vascular cells affected by diabetes, and pericyte loss leads to secondary changes in endothelial cells 9, 10 . A reduction in the expression of platelet-derived growth factor (PDGF) leads to a pericyte deficiency that is independent of diabetes 10, 11 . In Ins2 Akita mice, retinal levels of the PDGFB isoform were decreased (Extended Data Fig. 3a -e) and expression of the receptor PDGFRβ tended to increase. sEH inhibition increased PDGFB expression in retinas from wildtype and Ins2
Akita mice but failed to alter PDGFRβ levels. No reproducible alterations in vascular endothelial cell growth factor (VEGF), angiopoietins or their receptors, or in Notch signalling were detected between Ins2
Akita mice and their wild-type littermates (Extended Data Fig. 3f-m) . Thus, the Ins2
Akita model reproduces important features of early (non-proliferative) diabetic retinopathy and not the proliferative , and reduced N-cadherin expression (Fig. 2h ) as well as a loss of retinal vascular mural cells were apparent in retinas from Ins2 Akita mice (Extended Data Fig. 4a ). The loss of desminpositive mural cells coincided with altered patterning of the underlying N-cadherin (Fig. 2i) . Inter-endothelial cell contacts were also affected, and although vascular endothelial (VE)-cadherin staining clearly demarcated lateral membranes of endothelial cells in the primary and capillary layers of retinas from wild-type mice (Fig. 2j) , the continuity of the signal was disrupted in retinas from Ins2 Akita mice. Although the effect was patchy, discrete areas of the retina demonstrated only a weak punctate VE-cadherin staining, an effect regularly observed in diabetic retinopathy 13 . In diabetic mice, the apparent dissolution of endothelial cell-pericyte and inter-endothelial adherens junctions was largely normalized by sEH inhibitor treatment.
The significant changes in 19,20-DHDP levels in Ins2 Akita mice before and after sEH inhibitor treatment led us to hypothesize that 19,20-DHDP contributed to the progression of retinopathy by affecting Akita (Akita) and wild-type (WT) mice. b, Time course of retinal sEH expression. For gel source data, see Supplementary Fig. 1 . c, sEH activity in mouse retinas. d, sEH (red), glutamine synthetase (GS; green), glial fibrillary acidic protein (GFAP; blue) and DAPI (white) expression in retinas from patients without diabetic retinopathy (non-DR, n = 6), mild non-proliferative diabetic retinopathy (NPDR, n = 7) or severe NPDR (n = 6). e, f, Quantification of GFAP (e) and sEH (f) expression from sections shown in d. g, 19,20-EDP and 19,20-DHDP in vitreous humour from individuals without diabetic retinopathy (n = 14) or with diabetic retinopathy (DR, n = 17). h, Retinal levels of 19,20-EDP and 19,20-DHDP in 12-month-old mice treated with vehicle or sEH inhibitor (sEH-I). Scale bars, 50 μ m. n = 5 (b) or 6 (a, c, h) biologically independent samples per group. Data are mean ± s.e.m. P values determined by two-way ANOVA (b), Student's two-tailed t-test (c, g) or one-way ANOVA (e, f, h). Letter reSeArCH cadherin localization. Indeed, 19,20-DHDP (but not 19,20-EDP), disrupted VE-cadherin continuity in cultured endothelial cells (Fig. 3a) and increased endothelial cell permeability to dextran (Fig. 3b,  Extended Data Fig. 4b ). 19,20-DHDP also decreased transendothelial electrical resistance in cultured mouse brain microvascular endothelial cells (Fig. 3c) that develop junctions more similar to those normally found in the retina. 19,20-DHDP also induced VE-cadherin internalization, which was assessed using antibodies that recognized the extracellular domain of the protein (Fig. 3d, e) , and by immunoprecipitation of internalized versus surface VE-cadherin (Fig. 3f) . The effect of 19,20-DHDP was less pronounced than that of VEGF, which is reported to induce the internalization of VE-cadherin 14 . In endothelial cell monolayers, N-cadherin expression was low but it was clearly detectable in co-cultures of endothelial cells and pericytes, and enriched at contact points between the two cell types (Extended Data Fig. 4c-e) . In co-cultured cells, 19,20-DHDP decreased N-cadherin expression whereas 19,20-EDP and VEGF had no effect (Fig. 3g) . 19,20-DHDP also increased pericyte motility on endothelial cells, an effect mimicked by short interfering RNA (siRNA)-mediated downregulation of N-cadherin and reversed by its overexpression (Fig. 3h) . Moreover, in an ex vivo whole-mount retina model, 19,20-DHDP induced the migration of vascular pericytes into the extravascular space (Fig. 3k) . 19,20-DHDP also elicited the internalization of N-cadherin in pericytes (Fig. 3i, j, Extended Data Fig. 4f, g ), indicating that the diol may target VE-and N-cadherins via a common mechanism. 
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Mechanistically, docosahexaenoic acid and 19,20-DHDP are thought to exert their effects independently of a receptor by means of insertion into the lipid bilayer, a phenomenon previously linked with the redistribution of membrane cholesterol and proteins from lipid-raft to non-lipid-raft fractions of the membrane 15, 16 . Indeed, 19,20-DHDP inhibits γ-secretase and interferes with Notch signalling by eliciting the redistribution of presenilin 1 (PS1) 7 . Given that PS1 interacts with VE-cadherin 17 as well as N-cadherin 18-20 , we examined whether 19,20-DHDP disrupted the membrane localization of the cadherins. Both proteins were partially localized in lipid-raft fractions, and 19,20-DHDP, but not 19,20-EDP, was able to disrupt the lipid-raft association and membrane presentation of cadherins in endothelial cell-pericyte co-cultures (Extended Data Fig. 3n, o) . PS1 co-precipitated with VE-and N-cadherins from endothelial cell-pericyte co-cultures, and treatment with 19,20-DHDP markedly attenuated the binding of cadherins to the N-terminal fragment of PS1 (Fig. 3l ), whereas treatment with 19,20-EDP had no effect. 19,20-DHDP did not influence the association of either N-or VE-cadherin with p120 catenin, which is proposed to act as a molecular bridge between γ-secretase and cadherin-catenin complexes 21 . By contrast, VEGF elicited the phosphorylation of VE-cadherin and attenuated its association with p120 catenin, indicating a distinct mechanism of action (Extended Data Fig. 3p-r) . The co-localization of PS1 with VE-cadherin and N-cadherin could be visualized in retinas from wild-type mice (Fig. 3m ), but was disrupted in the areas from diabetic Ins2
Akita retinas that displayed the hallmarks of retinopathy. Treatment with sEH inhibitor maintained the co-localization of VE-and N-cadherin with PS1.
Protein complex assembly-disassembly is regulated by the cholesterol content of membrane microdomains 22 . A photoreactive cholesterol probe was used to demonstrate the association of PS1 with cholesterol in endothelial cell-pericyte co-cultures ( that is, endothelial cells (f), pericytes (g), extravascular pericytes (h), and acellular capillaries (i); n = 6 (GFP), 9 (sEH) or 8 (sEH + I, sEH ∆EH ) mice per group. j, Quantification of leaked TRITC-dextran. k, N-cadherin (cyan) and desmin (red) expression in retinas treated with adenoviruses. Note the perivascular desmin-positive protrusions that mark extravascular pericytes in sEH-treated retinas. l, VE-cadherin (green) and collagen IV (red) expression in retinas 14 days after adenovirus injection. Capillaries with abnormal VE-cadherin indicated by arrowheads. Scale bars, 50 μ m. n = 5 (b) or 6 (e, j-l) mice, or 6 biologically independent samples per group (c). Data are mean ± s.e.m. P values determined by one-way ANOVA.
Letter reSeArCH normalized the abnormal dynamic in membranes from Ephx2
−/− mice ( Fig. 3p and Extended Data Fig. 6a ).
To determine whether increased sEH expression causes retinopathy, an adenoviral approach was used to overexpress sEH in the retinas of non-diabetic wild-type mice. A strong and selective overexpression of sEH in Müller glial cells was achieved by intravitreal injection of the adeno viruses ( Fig. 4a ) and resulted in an increase in sEH activity (Fig. 4b) as well as fatty acid diol production (Extended Data Fig. 6b ), with the most prominent effects on the production of 19,20-DHDP (Fig. 4c) . These changes were not observed in retinas overexpressing GFP or an enzymatically inactive sEH mutant (sEH ∆EH ), or in retinas expressing wild-type sEH but treated with the inhibitor. Within 14 days of sEH adenovirus administration, there was a notable increase in vascular abnormalities, including decreased numbers of vascular-associated pericytes, increased numbers of extravascular pericytes and acellular capillaries, and vascular leakage ( Fig. 4d -j, Extended Data Fig. 7 ). The increase in extravascular (migrating) pericytes induced by sEH overexpression coincided with a reduction in N-cadherin expression (Fig. 4k) and disrupted VE-cadherin patterning (Fig. 4l) . All of these changes were abrogated in animals treated with sEH inhibitor. An adeno-associated virus used to specifically target Müller cells using the retinaldehyde binding protein 1 promoter, resulted in a slower and more modest increase in retinal sEH expression. However, changes in the retinal vasculature 3 months after administration of virus to non-diabetic mice phenocopied that of non-proliferative diabetic retinopathy (compare Extended Data Fig. 8 with Fig. 2a) .
Taken together, our results link early (non-proliferative) diabetic retinopathy with an increase in sEH expression and increased retinal levels of its product, 19,20-DHDP. Moreover, the observations suggest that targeting sEH is an attractive therapeutic approach to delay the development and progression of diabetic retinopathy.
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Materials. The sEH inhibitor trans-4-[4-(3-adamantan-1-ylureido)cyclohexy-
loxy]-benzoic acid (t-AUCB) was synthesized as described 24 . Cell culture media were purchased from Gibco (Invitrogen), 19,20-epoxydocosapentaenoic acid and 19,20-dihydroxydocosapentaenoic acid were obtained from Cayman Europe.
Animals and in vivo treatment. Ins2
Akita (C57BL/6-Ins2 Akita /J) mice carrying a mutation in the insulin 2 gene were obtained from The Jackson Laboratory. The colony was generated by breeding a C57BL/6J inbred female with a heterozygous male. In the present study, only male animals were studied. At the age of 6-8 weeks, animals were randomly allocated into two groups and treated with either vehicle (0.3% ethanol) or sEH inhibitor (t-AUCB, 2 mg l −1 ) in the drinking water for a further 10 months. All animals were housed in conditions that conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23). Both the University Animal Care Committee and the Federal Authority for Animal Research at the Regierungspräsidium Darmstadt (Germany) approved the study protocol (#F28/38, #FU1012 and #FU1153). For the isolation of organs, mice were euthanized using 4% isoflurane in air and subsequent exsanguination.
For the viral-mediated overexpression of the sEH in the retina, 6-8-week-old male C57BL/6J mice (Charles River), were anaesthetized with 2% isoflurane and 1 drop of 0.5% proxymetacainhydrochlorid (Ursapharm) was applied on top of the cornea. The iris was dilated using 5% phenylephrine hydrochloride (Ursapharm), and mice were intravitreally injected with the appropriate adenoviruses (1.5 × 10 7 plaque-forming units per microlitre) or adeno-associated viruses (10 10 genomic copies per microlitre). Mice were randomly allocated to the different adenovirus groups and injections were performed by ultramicropump III injector (World Precision Instruments) with self-pulled glass pipettes at 10 nl s −1 .
Generation of adenoviruses and adeno-associated viruses.
The adenovirus encoding human sEH under the control of a CMV promoter was generated as previously reported 7 . To generate the sEH mutant deficient in epoxide hydrolase activity (sEH ∆EH ) the tyrosine residues Tyr383 and Tyr466 were mutated to phenylalanine in the pAd-shuttle sEH vector using the following primers (Biospring GmbH: Y381F: 5′ -GCCAACCCAGTATTTGATTTCCAGCTCTACTTCCAAGAACCAGG-3′, Y465F: 5′ -GTCCTCTAAACTGGTTCCGAAACATGGAAAGGAACTGGAAG TGG-3′ ). After DpnI restriction enzyme digestion the DNA was transformed in Escherichia coli and the mutations were confirmed by sequencing (Eurofins MWG Operon). Then adenoviruses were then generated as described.
The AAV6-derived capsid variant ShH10 and the AAV 2 RLBP1 GFP WPRE bGHpolyA vector with a Müller cell specific retinaldehyde binding protein 1 promoter 25 (provided by J. Wijnholds) were used to overexpress the human sEH in mouse Müller glial cells. In brief, the Myc-and His-tagged sEH used for the adenovirus was subcloned from the pcDNA3.1/myc-His vector (Thermo Fisher Scientific) via EcoRI and AflII after T4 polymerase treatment in the AgeI digested and T4 polymerase blunted AAV 2 RLBP1 GFP WPRE bGHpolyA vector. The orientation of the insert was confirmed by control digestion with XbaI and BamHI (NEB), as well as by sequencing. Ligation reaction was performed with the T4 ligase (NEB). Cell culture. Mouse brain endothelial cells were isolated and cultured as previously described 26, 27 and human brain vascular pericytes were purchased from ScienCell Research Laboratories. Human umbilical vein endothelial cells (HUVECs) were isolated and purified using VE-cadherin (CD144) antibody-coated magnetic beads (Dynal Biotech) and cultured as described 28 . The human umbilical cords were obtained from local hospitals in Frankfurt am Main, and the use of human material in this study conforms to the principles outlined in the Declaration of Helsinki. The isolation of human cells was approved by the ethics committee at the GoetheUniversity, Frankfurt, Germany. ) in the presence of sEH inhibitor (t-AUCB, 10 mM) at 37 °C for 4 h. Transwell-based co-culture. Polyester transwell inserts (0.4-μ m pore diameter; Corning) were coated with fibronectin for 1 h at room temperature. HUVECs were seeded on the underside of the inserts. After 2 days, inserts were turned over and placed into the 12-well plate with endothelial cell monolayers facing down in the dish. Pericytes were then seeded on the upper side of inserts and maintained for a further 3 days. Human retina samples. Eyes were isolated during autopsy (with consent from a relative), and retinas were embedded in paraffin were obtained from the Wilmer Eye Institute Ocular Pathology Archives; with approval from the Johns Hopkins School of Medicine Institutional Review Board (study number CR00014650), and the Eye Bank of the Center of Ophthalmology; with approval from the Ethics Committee of the University of Cologne (reference number 14-247), and followed the tenets of the Declaration of Helsinki. Tissues were rehydrated and embedded in paraffin. Sections (5 μ m) were cut on the horizontal level of the optic nerve and mounted on coated microscopic slides. Human vitreous humour samples. Vitreous samples were obtained, with informed consent, from 17 patients undergoing vitrectomy for proliferative diabetic retinopathy and 14 patients with macula disease not related to diabetes. All samples were collected by pars plana vitrectomy, centrifuged at 16,000g at 4 °C for 15 min and archived at − 80 °C until further use. The study was approved by Henan Eye Institute Clinical Research Ethics committee under the approval number HNEECKY-2015(3). All studies involving the recovery of human material followed the tenets of the Declaration of Helsinki. Immunohistochemistry and immunofluorescence: retinal whole mount. Retinas for whole-mount immunostaining were fixed in 4% paraformaldehyde (PFA) for 2 h at room temperature, or overnight at 4 °C. After fixation, retinas were blocked and permeabilized in blocking buffer (1% BSA and 0.5% Triton X-100 in PBS) overnight at 4 °C. For mouse antibodies, samples were washed and blocked with mouse IgG blocking reagent as suggested by the manufacturer (MKB-2213 Vector) for 1 h at room temperature. Primary antibodies were diluted in blocking buffer and incubated overnight at 4 °C. The following antibodies were used: VE-cadherin (1:200, AF1002 R&D Systems), α -smooth muscle actin-cy3 (1:500, C6198 Sigma), N-cadherin (1:200, 33-3900 Life Technologies), collagen IV (1:500, 1340-01 Southern Biotech), presenilin 1 (1:200, MAB1563 Millipore) and desmin (1:500, ab15200 Abcam). For secondary detection, Alexa Fluor-coupled secondary antibodies (1:200) were used. Cell nuclei were visualized with DAPI (0.2 μ g ml
, D9542 Sigma). After antibody staining, retinas were post-fixed with 4% PFA for 10 min before flat-mounting in mounting medium (DAKO).
Immunohistochemistry and immunofluorescence: retinal cross-sections.
Immunofluorescent detection of sEH was performed in cryopreserved mouse tissue sections (10 μ m) and paraffin-embedded human tissue (5 μ m). The antibody against sEH (rabbit polyclonal antibody, 1:250) was provided by M. Arand. Antibodies against GFAP (1:1,000, AB5541), and glutamine synthetase (1:1,000, MAB302) were from Millipore, and the antibody against AQP4 (1:500, sc-9887) was from Santa Cruz. For secondary detection, Alexa Fluor-coupled secondary antibodies (1:200) were used. Fluorescent images were taken using a confocal microscope (Carl Zeiss LSM-780). The average signal intensities of sEH and GFAP on human retinal sections (ganglion cell layer was excluded) were quantified by ImageJ software (NIH). Cultured cells. Cells or cells on transwell filters were fixed with 4% PFA for 10 min at room temperature. After washing with PBS, samples were blocked and permeabilized with 1% BSA, 5% horse serum, 0.5% Triton X-100 at room temperature for 2 h or at 4 °C overnight before being exposed to primary antibody (4 °C, overnight). After extensive washing and exposure to Alexa Fluor-coupled secondary antibodies (1:200, 2 h, room temperature) samples were mounted in fluorescent mounting medium and analysed with a confocal microscope (Leica SP8 confocal microscope and LASX software; or Carl Zeiss LSM-780 and ZEN software) as described 7, 29 .
Retinal digest preparation.
Retinal vascular preparations were performed using a pepsin-trypsin digestion method as described 30 . In brief, eyes were enucleated and immediately fixed in 4% PFA (PBS buffered, pH 7.4) for two days and washed in distilled water for 1 h at 37 °C. A combined pepsin (5% pepsin in 0.2% HCl for 1 h)-trypsin (2.5% in 0.2 M Tris pH 7.4 for 30 min) digestion was used to isolate the retinal vasculature. The samples were air-dried and stained with periodic acid Schiff and haematoxylin to highlight basement membranes and nuclei of capillaries. The total numbers of endothelial cells, pericytes and migrating pericytes were counted in 10 randomly selected fields ( 400× magnification) per retina using a Cell F image system with a morphometric analysing software (XC10 Peltier-cooled digital camera, Olympus Europa), and the numbers were normalized to the relative capillary density (number of cells per mm 2 capillary area). Subsequently, according to their localization within the capillary tree and their position relative to adjacent endothelial cells, pericytes with triangular nuclei in which at least one lateral side of the triangular nuclei projecting into the extravascular interstitium was longer than the base in contact with the capillary, were defined as migrating pericytes. Acellular capillary segments were quantified using an integration ocular with 100 grids (Olympus, 400× magnification) and the total numbers were normalized to mm 2 of retinal area. All samples were evaluated in a blinded fashion. sEH activity assay. Retinas were homogenized in RIPA lysis buffer (50 mM TrisHCl pH 7.5, 150 mM NaCl, 10 mM sodium pyrophosphate (NaPPi), 20 mM NaF, 1% sodium deoxycholate. 1% Triton X-100 and 0.1% SDS) and the homogenate was used to determine the sEH activity. In brief, reactions were performed with 5 μ g protein at 37 °C for 10 min in 100 μ l of potassium phosphate buffer (100 mM, pH 7.2). Reactions were started by the addition of 14,15-EET (10 μ M), stopped Letter reSeArCH on ice and immediately extracted twice with ethyl acetate (0.7 ml). For liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, one-tenth of the sample was spiked with a deuterated internal standard (14,15-EET-d8). After evaporation of the solvent in a vacuum block under a gentle stream of nitrogen, the residues were reconstituted with 50 μ l of methanol:water (1:1, v/v) and determined with a Sciex API4000 mass spectrometer operating in multiple reaction monitoring (MRM) mode as described 31 . Chromatographic separation was performed on a Gemini C18 column (150 × 2 mm I.D., 5 μ m particle size; Phenomenex). Epoxide/diol profiling. Human vitreous humour (200 μ l) or mouse retina lysates were mixed with 500 μ l methanol and 300 μ l of 10 M sodium hydroxide and deuterated internal standards. The samples were hydrolysed for 30 min at 60 °C and then neutralized with acetic acid and adjusted to pH 6.2. A solid-phase extraction procedure using Agilent Bond-Elut-Certify II was performed as described 32 . The measurements were performed by LIPIDOMIX GmbH with a Triplequad LC-MS/ MS (Agilent 6460/1200SL, Agilent Technologies) equipped with a Phenomenex Kinetex Column (150 mm × 2.1 mm, 2.6 μ m, Phenomenex). Chromatography was achieved under gradient conditions with acetonitrile/0.1% formic acid in water as the mobile phase, a flow rate of 0.3 ml min −1 and a run time of 16 min. The injection volume was 7.5 μ l. After optimization, the following MS/MS conditions were used: electrospray ionization (ESI) in negative mode, capillary voltage 3,500 V, nozzle voltage 1,500 V, drying gas 210 °C per 7 l per min, sheath gas 350 °C per 11 l per min and nebulizer pressure 30 psi. Standard curves containing the following standards were used for quantification: 5,6-EET, 5,6-DHET, 8,9-EET, 8,9-DHET, 11,12-EET, 11,12-DHET, 14,15-EET, 14,15-DHET, 9S-HODE, 13S-HODE, 9,10-EpOME, 9,10-DiHOME, 12,13-EpOME, 12,13-DiHOME, 14,15-EpETE, 18S-HEPE, 19,20-EDP and 19,20-DHDP (Cayman Europe). Concentrations of the standards ranged from 0.1 ng ml −1 to 500 ng ml −1 for all the lipids. All samples and dilutions of the standards were spiked with internal deuterated standards: metabolite concentrations were determined by reference to the standards. Signalto-noise ratios ≥ 3 were required for a peak to be considered identifiable and ≥ 10 to be quantifiable. In vitro pericyte migration assay. HUVECs were isolated and cultured as described 33 , seeded on μ -slides (ibidi) and grown to confluence. Pericytes were labelled with cell tracker green (Invitrogen) and added to the endothelial cell monolayer and co-cultured for 24 h. Cells were then treated with solvent (0.03% DMSO), 19,20-EDP (3 μ M) or 19,20-DHDP (3 μ M) in the presence of t-AUCB (10 μ M). Cells were incubated in an IncuCyte imaging system (Essen Bioscience) that took photographs automatically every 15 min for 24 h. Pericyte movement on top of the endothelial cell monolayer were tracked manually and analysed with ImageJ (NIH). Cells with total migration distance less than 150 μ m in 24 h were excluded and in total 120 cells were tracked. In some experiments pericytes were treated with small interfering RNA directed against N-cadherin (sc-29403, Santa Cruz) or an N-cadherin overexpression plasmid (Addgene, 18870). Transfection was performed with Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions and a scrambled control siRNA was used as control. Experiments were performed 4 times independently and 4 different cell batches were used. Retinal explants. Eyes from 7-month-old animals were enucleated and immersed in ice-cold HBSS containing penicillin (100 U ml −1 ) and streptomycin (100 μ g ml
−1
). Retinas were carefully dissected under a stereomicroscope and divided into four quadrants with four deep radial incisions. The explants were transferred onto tissue culture inserts (0.4 μ m pore, Millipore) with the retinal ganglion cell side facing up. The inserts were placed into the wells of a 6-well plate. A serum-free retinal explant media (Neurobasal A, Invitrogen) supplemented with 2% B27 (Invitrogen), 1% N 2 (Invitrogen), l-glutamine (0.8 mM), penicillin (100 U ml −1 ), and streptomycin (100 μ g ml ) were added to the bottom of the wells and 3 μ l of media was dropped on top of the retina to keep it moist. Retinal explant cultures were maintained in humidified incubators (37 °C, 5% CO 2 ) and treated with solvent (0.03% DMSO), 19,20-EDP (3 μ M) or 19,20-DHDP (3 μ M) in the presence of sEH inhibitor (t-AUCB, 10 μ M). After 4 days, retinas were fixed and processed as described above. Permeability assays: retinal barrier function. Animals were anaesthetized (ketamine 100 mg kg −1 and xylazine 10 mg kg −1 body weight) and injected (intravenously) with FITC-BSA (Sigma). After 1 h, animals were killed and eyes were enucleated. After fixing with 4% PFA for 2 h, retinas were dissected and flatmounted and analysed with confocal microscopy. To quantify FITC-BSA leakage in the retina, some animals were perfused with pre-warmed PBS to remove vascular FITC-BSA before the retinas were isolated. Thereafter, the FITC-BSA fluorescence signal in retinal homogenates was assessed (excitation λ 485 nm, emission λ 530 nm) using a plate reader (PerkinElmer). To study permeability in retinas from mice treated with adenoviruses, tetramethylrhodamine isothiocyanate-conjugated dextran (TRITC-dextran) average molecular mass 65-85 kDa, (Sigma) was used. Fluorescence images were taken 5 min after tracer injection and the dextran remaining in retinal tissues after perfusion with PBS was assessed (excitation λ 550 nm, emission λ 580 nm) using a plate reader (PerkinElmer). Blood was taken immediately before perfusion with PBS, and fluorescence intensity in the plasma was used for normalization. Transendothelial electrical resistance. Impedance measurements were performed using isolated mouse brain microvascular endothelial cells with a cellZscope device (nanoAnalytics) as described 34 . After reaching confluence, indicated by a plateau in the TEER, cells were treated with solvent (0.025% DMSO), 19,20-EDP (3 μ M) or 19,20-DHDP (3 μ M). Measurements were performed four times in quadruplicate with endothelial cells from eight different cell preparations. Dextran permeability. Permeability through the mouse brain endothelial cell monolayer was measured as described 35 . In brief, primary endothelial cells were plated (10 5 cells cm −2
) onto fibronectin-coated 24-well polyethylene terephthalate Transwell inserts (Greiner Bio-One) and cultured to confluency. Cells were treated with solvent, 19,20-EDP or 19,20-DHDP and after 24 h dextrans of defined molecular mass and fluorescence-that is, 0.45 kDa Lucifer yellow-dextran (5 μ M, Sigma, excitation λ 425 nm, emission λ 525 nm), 3 kDa dextran-TXR (2.5 μ M, Invitrogen, excitation λ 595 nm, emission λ 625 nm), 20 kDa dextran-TMR (5 μ M, Sigma, excitation λ 550 nm, emission λ 580 nm) and 70 kDa dextran-FITC (2.5 μ M, Sigma, excitation λ 490 nm, emission λ 520 nm) were added to the apical compartment. After 1 h, the transfer of dextrans to the lower compartment was assessed by a fluorescence reader (Tecan). The data are expressed as the percentage of permeability normalized to the permeability coefficient for the control conditions of untreated cells. VE-and N-cadherin internalization assays. VE-cadherin internalization was determined as described 36 . Endothelial cells were cultured on culture slides (BD Biosciences) coated with crosslinked gelatine until confluent and starved with 2% FCS overnight. Cells were then incubated with antibody against extracellular domain of human VE-cadherin (clone BV6, ALX-803-305 Enzo Life Sciences) at 4 °C for 1 h in MCDB 131 with 1% BSA medium. Unbound antibody was removed by rinsing cells with ice-cold MCDB 131 medium. After washing, cells were treated with solvent (0.03% DMSO), 19,20-EDP (3 μ M), 19,20-DHDP (3 μ M) or recombinant human VEGFA (30 ng ml −1 ) in the present of sEH inhibitor (t-AUCB, 10 mM) and maintained at 37 °C for 3 h. To block the degradation of internalized VE-cadherin chloroquine (300 μ M) was added to the incubation medium. To assess internalized endogenous VE-cadherin, cells were washed with ice-cold acid wash buffer (Hank's buffer, pH 2.7, containing 25 mM glycine and 1% BSA). Cells were fixed with 4% PFA for 15 min at 4 °C and then processed for immunofluorescence.
To assess N-cadherin internalization, pericytes were incubated with a mouse monoclonal antibody against the extracellular domain of human N-cadherin (clone 8C11, 350802 BioLegend) at 4 °C for 1 h in DMEM containing 1% BSA. After removing unbound antibodies with ice-cold DMEM medium, cells were treated with solvent (0.03% DMSO), 19,20-EDP (3 μ Μ ) or 19,20-DHDP (3 μ M) in the present of sEH inhibitor (t-AUCB, 10 mM) and leupeptin (100 μ g ml −1 ) at 37 °C for 3, 6 or 10 h. After rinsing with PBS, cells were fixed with 4% PFA for 15 min. Antibodies remaining on the cell surface were blocked with an excess of anti-mouse IgG Alexa 633-conjugated antibody (Life Technologies, 1:100) for 2 h. Thereafter, samples were washed with PBS and permeabilized with 0.5% Triton X-100. Endocytosed N-cadherin was visualized with anti-mouse IgG Alexa 488-conjugated antibody (Life Technologies, 1:400). Samples were imaged with a SP8 confocal microscope (Leica) and internalized particles were quantified using ImageJ software (NIH). Surface and internalized VE-cadherin immunoprecipitation. Confluent HUVECs were incubated with antibodies recognizing the extracellular domains of human VE-cadherin (BV6 antibody) at 4 °C (1 h) and then treated with solvent (0.03% DMSO), 19,20-EDP (3 μ M) or 19,20-DHDP (3 μ M) at 37 °C for 3 h. After an acid wash to remove the surface bound antibody, cells were homogenized with lysis buffer (20 mM HEPES pH 7.5, 1.5 mM MgCl 2 , 5 mM EGTA, 150 mM NaCl, 1% Triton X-100, 0.5% glycerol). For surface VE-cadherin immunoprecipitation, endothelial cells were treated 19,20-EDP or 19,20-DHDP at 37 °C for 3 h, and then incubated with VE-cadherin BV6 antibodies at 4 °C for 1 h. After rinsing with ice-cold MCDB 131 medium to remove unbound antibody, cells were lysed with the same buffer as above. After centrifugation at 17,000g for 10 min, supernatants were incubated with protein G agarose (Pierce) for 2 h. Samples were washed with lysis buffer and analysed by SDS-PAGE. Immunoprecipitation of VE-and N-cadherins in endothelial cell-pericyte co-cultures. HUVECs were isolated and cultured to give confluent monolayers. Pericytes were trypsinized and seeded on top of the endothelial cell monolayer (pericytes:endoethlial cells = 1:2) for an additional 24 h. After treatment with solvent (0.03% DMSO), 19,20-EDP (3 μ M) or 19,20-DHDP (3 μ M) for 4 h, cells were collected and lysed in PBS by sonication. After centrifugation at 16,000g for 15 min, membrane proteins were solubilized within lysis buffer (20 mM HEPES pH 7.5, 1.5 mM MgCl 2 , 5 mM EGTA, 150 mM NaCl, 1% digitonin, 0.5% glycerol) with protease inhibitor cocktail tablets (Roche). After pre-incubated with protein A&G agarose (Pierce) for 2 h, supernatants were incubated with antibody against VE-cadherin (sc-28644 Santa Cruz) or N-cadherin (33-3900 Life Technologies) overnight at 4 °C. Then samples were incubated with protein A&G agarose (Pierce) for 2 h. Samples were washed with lysis buffer and analysed by SDS-PAGE. Photoreactive cholesterol loading and click chemistry. A photoreactive 'clickable' cholesterol probe (hex-5′ -ynyl 3β -hydroxy-6-diazirinyl-5α -cholan-24-oate; Avanti Polar Lipids) was used as described 23 . In brief, a cholesterol probe stock solution was prepared (2 mM in 50 mg ml −1 methyl-β -cyclodextrin) and rotated overnight. Endothelial cells and pericytes were co-cultured for 24 h and treated with lovastatin (5 μ g ml −1
, Merck) and t-AUCB (10 μ M) for an additional 2 h. Then cells were incubated with the cholesterol probe (10 μ M) for 30 min at 37 °C. After removing the unbound probe, cells were treated with solvent (0.03% DMSO), 19,20-EDP (3 μ M) or 19,20-DHDP (3 μ M) in the presence of lovastatin and t-AUCB (10 μ M) for 4 h. After exposure to UV light (λ 365 nm) in a crosslinker (Vilber) for 5 min, cells were collected and processed for immunoprecipitation as described above. After immunoprecipitation, the cholesterol probe crosslinked to the proteins of interest was labelled with biotin-azide (Sigma) using a CuAAC-based click chemistry reaction buffer kit according to the manufacturer's instructions (Jena Bioscience). RT-qPCR. Total RNA from retinas was extracted using an RNeasy kit (QIAGEN), and equal amounts (1 μ g) of total RNA was reverse transcribed (Superscript III; Invitrogen). Gene expression levels were detected using SYBR Green (Absolute QPCR SYBR Green Mix; Thermo Fisher Scientific). The relative expression levels of the different genes studied was calculated using the 2 −∆∆Ct method with 18S RNA as a reference. The primer sequences used were as follows: 18S forward 5′-CTTTGGTCGCTCGCTCCTC-3′, 18S reverse 5′-CTGACCGG-GTTGGTTTTGAT-3′; Pdgfa forward 5′ -CCTGTGCC CATTCGCAGGAAGAGA-3′, Pdg fa reverse 5′-TTGGCCACCTTGA CACTGCGGTG-3′; Pdgfb forward 5′-ATCGCCGAGTGCAAGACGCG-3′, Pdgfb reverse 5′-AAGCACCATTGGCCGTCCGA-3′; Pdgfc forward 5′-TGCA GCTCTCCAGCGACAAGG-3′, Pdgfc reverse 5′-CGGGCTGTGGATGCTCC CAT-3′; Pdgfd forward 5′-CCGGAAGCAGCCTCAGAGACC-3′, Pdgfd reverse 5′-AGCAGTGAGAGTGGGGTCCGT-3′; Vegf (also known as Vegfa) forward 5′-GCACTGGACCCTGGCTTTACTGCTGTA-3′, Vegf reverse 5′-GAACTTGATC ACTTCATGGGACTTCTGCTC-3′; Angpt1 forward 5′-CGGTGCCGATT TCAGCACGAA-3′, Angpt1 reverse 5′-GGCCACAGGCATCGAACCACC-3′; Angpt2 forward 5′-GGGAAGGCAACGAGGCGCATT-3′, Angpt2 reverse 5′-CGCGGTCCCCGTGAGTCCTG-3′; Tie1 forward 5′-ACAGCCGG CGCTTCAAGGTC-3′, Tie1 reverse 5′-AAGCTGACGGCTCTGCTTGGC-3′; Tie2 (also known as Tek) forward 5′-ATGGCTCAGGCATTCCAGAACAG-3′, Tie2 reverse 5′-TGGCCTTCCTGTTAAGGGCCAGA-3′; Hes1 forward 5′-GAGGCGAA GGGCAAGAATAAA-3′, Hes1 reverse 5′-GTGGACAGGAAGCGGGTCA-3′; Hey1 forward 5′-TGAGCTGAGAAGGCTGGTAC -3′, Hey1 reverse 5′-ACCCCAAACTC CGATAGTC -3′; Jag1 forward 5′-TCTCTGACCCCTGCCATAAC-3, Jag1 reverse 5′-TTGAATCCATTCACCAGATCC-3′ . siRNA. To knockdown N-cadherin in pericytes, siRNA directed against N-cadherin (sc-29403, Santa Cruz) was used. Transfection was performed with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions, and a scrambled control siRNA was used as control. Immunoblotting. Retinas or cells were lysed in RIPA lysis buffer (50 mM Tris-HCL pH 7.5, 150 mM NaCl, 10 mM NaPPi, 20 mM NaF, 1% sodium deoxycholate, 1% Triton X-100 and 0.1% SDS) and detergent-soluble proteins were resuspended in SDS-PAGE sample buffer. Samples were separated by SDS-PAGE and subjected to western blotting as described 37 . Membranes were blocked in 3% BSA in PBS, incubated with primary and horseradish peroxidase-conjugated secondary antibodies in blocking solution, and detection was performed with a LumiLight plus western blotting substrate (Roche). For detection using the LI-COR system, after incubating with primary antibodies, the membranes were incubated for 1 h with IRDye800CW-and IRDye680-conjugated secondary antibodies (LI-COR Biosciences). The blots were then washed and visualized by scanning the membrane on an Odyssey Clx Imaging System (LI-COR Biosciences) with both 700 and 800 nm channels. Lipid rafts. Lipid rafts were isolated as described, with modifications 38 . In brief, cells were collected by scraping and homogenized at 4 °C in sodium carbonate (0.5 M, pH 11) using a glass homogenizer, followed by sonication. Then, equal amounts of protein were adjusted to a final sucrose concentration of 45% (final volume, 4 ml) and transferred to 12 ml ultracentrifuge tubes. A discontinuous sucrose gradient was then formed by sequentially overlaying 4 ml of 35% and 4 ml of 5% sucrose. Samples were subjected to ultracentrifugation (151,000g, 4 °C for 20 h) using a Beckman SW 41 rotor. After centrifugation, 12 × 1-ml fractions (bottom to top) were collected using a capillary tube connected to a peristaltic pump, and equal volumes of each fraction were analysed by SDS-PAGE using antibodies against flotillin 1 (1: 2000, 610820 BD Biosciences), VE-cadherin (1:1,000, sc-28644 Santa Cruz) and N-cadherin (1:1,000, 33-3900 Life Technologies). Statistical analysis. Data are expressed as mean ± s.e.m. Statistical evaluation was performed using Student's t-test for unpaired data, one-way ANOVA followed by a Newman-Keuls test or ANOVA for repeated measures where appropriate. Values of P < 0.05 were considered statistically significant. No statistical methods were used to predetermine sample size. Data availability. The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information. (Fig.1 a-d; Fig.2; Fig.3 m; Fig.4 ; Extended data Fig.1 , 2, 3a, 4a-m, 6b, 7 and 8): numbers were chosen based on previous experience (sample sizes determined by animal license application) and pilot experiments for the current project. Human samples (Fig.1e-h ): based on the availability of those materials and the achievement of statistical significance. In vitro cell culture and ex vivo treatment (Fig.3 a-l and n-o; Extended data Fig.3b -g, 4n-r, 5): numbers were chosen based on previous experience based on pilot experiments for the current project.
Letter reSeArCH
Data exclusions
Describe any data exclusions. Fig.1 h, based on patient diagnosis note, vitreous samples with severe hemorrhage were excluded from the analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Animals treated with sEH inhibitor: after genotyping, Ins2Akita mice and their littermates (male, 6 weeks old) were randomly divided into two groups to receive treatment with vehicle or with sEH inhibitor. Animals with intravitreal injection of adenovirus: C57BL6 male littermates (6-10 weeks old) were randomly divided into 4 groups to receive virus injection and then treatment with vehicle or with sEH inhibitor. Animals with intravitreal injection of AAVs: C57BL6 male littermates (6-8 weeks old) were randomly divided into 3 groups to receive virus injection and then treatment with vehicle or with sEH inhibitor.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis. 
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
IImage J (NIH) was used for analyzing of immunostaining intensity in Fig.1f and g, and for analyzing of internalized particles shown in Fig.3d -e, i-j and Extended Data Fig.3f -g. BIO-1D software (Vilber, Eberhardzell, Germany) was used to analyze the intensity of bands on Western blots. LASX and ZEN software was used to acquire images using confocal microscopes i.e. Leica SP8 confocal microscope and LASX software (Wetzlar, Germany), or Carl Zeiss LSM-780 and ZEN software (Jena, Germany).
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
The adenoviruses and AAVs used in the study are available for non-profit researchers.
